Warren Hurlburt
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
Growth Hormone and Insulin-like Growth Factors, Cancer, Hypoxia, and Metabolism, Metabolism, Diabetes, and Cancer, Herpesvirus Infections and Treatments, HER2/EGFR in Cancer Research
Most-Cited Works
- → BMS-754807, a small molecule inhibitor of insulin-like growth factor-1R/IR(2009)278 cited
- → The protease of herpes simplex virus type 1 is essential for functional capsid formation and viral growth(1994)207 cited
- → Tumor Development by Transgenic Expression of a Constitutively Active Insulin-Like Growth Factor I Receptor(2005)203 cited
- → The Mechanisms of Differential Sensitivity to an Insulin-like Growth Factor-1 Receptor Inhibitor (BMS-536924) and Rationale for Combining with EGFR/HER2 Inhibitors(2008)163 cited
- → Discovery of a 1H-Benzoimidazol-2-yl)-1H-pyridin-2-one (BMS-536924) Inhibitor of Insulin-like Growth Factor I Receptor Kinase with in Vivo Antitumor Activity(2005)134 cited
- → Differential Mechanisms of Acquired Resistance to Insulin-like Growth Factor-I Receptor Antibody Therapy or to a Small-Molecule Inhibitor, BMS-754807, in a Human Rhabdomyosarcoma Model(2010)115 cited
- → Discovery of a 2,4-Disubstituted Pyrrolo[1,2-f][1,2,4]triazine Inhibitor (BMS-754807) of Insulin-like Growth Factor Receptor (IGF-1R) Kinase in Clinical Development(2009)94 cited
- → Phenotype of the herpes simplex virus type 1 protease substrate ICP35 mutant virus(1994)57 cited
- → The UL8 component of the herpes simplex virus helicase-primase complex stimulates primer synthesis by a subassembly of the UL5 and UL52 components.(1994)53 cited
- → The C-terminal 25 amino acids of the protease and its substrate ICP35 of herpes simplex virus type 1 are involved in the formation of sealed capsids(1995)52 cited